Top Markets
Coin of the day
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.

China BCT Pharmacy Group, Inc.

CNBI
Classement en actions #42162
China BCT Pharmacy Group, Inc. functions as a comprehensive pharmaceutical... China BCT Pharmacy Group, Inc. functions as a comprehensive pharmaceutical enterprise within the People's Republic of China, conducting its operations through various subsidiary companies. Its business activities are primarily categorized into three distinct divisions: Pharmaceutical Distribution, Retail Pharmacy, and Pharmaceutical Manufacturing. The Pharmaceutical Distribution division procures a diverse array of medicinal goods from various suppliers, subsequently supplying them to a broad client base that includes hospitals, retail drug stores, other wholesale distributors, clinics, medical centers, and individual consumers. Its extensive inventory, numbering approximately 8,000 distinct items, encompasses both branded and generic prescription medications, over-the-counter remedies, traditional Western and Chinese medicines, personal care products, medical supplies, Chinese herbal remedies, and medical instruments. Through its Retail Pharmacy segment, the company manages a network of 196 directly owned pharmacies, predominantly located in Guangxi province, operating under the "Baicaotang" brand. These outlets provide expert pharmaceutical services and offer a broad assortment of health-related products. This range includes prescription and non-prescription drugs, refined and roughly processed traditional Chinese herbal medicines, family planning items, and various other pharmaceutical and healthcare products. The Pharmaceutical Manufacturing division, operating under the "Asio" brand, is responsible for producing and marketing a range of generic and clinical pharmaceuticals. This includes treatments for inflammation and bacterial infections, oncology drugs, cardiovascular medications, and hepatitis therapies. Key products manufactured by the company include Levodopa, Tabellae Sarcandrae, Rotandine Sulfate, Corydalis Saxicola Bunting, and Ethacridine Lactate injection. The company was originally known as China Baicaotang Medicine Limited before adopting its current name, China BCT Pharmacy Group, Inc., in March 2010. Its corporate headquarters are situated in Liuzhou, People's Republic of China.
Prix de l'action
$0.0001
Dernière synchronisation: 2025-06-02
Capitalisation boursière
$3.82K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
CN
Échange China BCT Pharmacy Group, Inc. (CNBI)

Catégorie

Marge opérationnelle de China BCT Pharmacy Group, Inc. (CNBI)
Marge opérationnelle au 2026 TTM : 0.00%
Selon les derniers rapports financiers et le cours de l'action de China BCT Pharmacy Group, Inc., la marge opérationnelle actuelle (TTM) est de 0.00%. À la fin de 2026, elle était de 0.00%.
Historique de la marge opérationnelle pour China BCT Pharmacy Group, Inc. de 2026 à 2026
Marge opérationnelle à la fin de chaque année
Année Marge opérationnelle Changez
Pas assez de données pour les dates fournies.
Marge opérationnelle pour des entreprises similaires ou concurrentes
Entreprise Marge opérationnelle Différence de Marge Opérationnelle Pays
67.93% -
US
0.00% -
SE
0.00% -
FR
0.00% -
IT
0.77% -
US
Qu'est-ce que la Marge opérationnelle d'une entreprise ?
La Marge opérationnelle est un indicateur clé pour évaluer la rentabilité d'une entreprise. Une marge d'exploitation plus élevée est généralement préférable car elle montre qu'une entreprise peut vendre ses produits ou services bien au-dessus de leurs coûts de production. Elle se calcule en divisant les bénéfices par le chiffre d'affaires.